v3.26.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
 6 Months Ended
Jun. 30, 2026
USD ($)
Cash flows from operating activities:  
Net income/(loss) $ (905,902)
Adjustments to reconcile net income/(loss) to net cash used in operating activities  
Allocated expense for warrant issuance cost 270,678
Interest reinvested in the Trust Account (207,092)
Gain from change in fair value of public warrant liabilities 717,600
Changes in operating assets and liabilities:  
Accrued expenses, formation and offering costs (365,090)
Net cash used in operating activities (489,806)
Cash flows from investing activities:  
Cash deposited in Trust Account (358,800,000)
Net cash used in investing activities (358,800,000)
Cash flows from financing activities:  
Proceeds from sale of Units in initial public offering 358,800,000
Proceeds from sale of Private Placement Shares to Sponsor 2,250,000
Payment of accrued offering costs (316,700)
Payment of underwriters’ discounts and commissions (250,000)
Proceeds from notes payable - related party 166,327
Repayment of notes payable - related party (236,120)
Net cash provided by financing activities 360,413,507
Net change in cash 1,123,701
Cash at beginning of period 0
Cash at end of period 1,123,701
Supplemental disclosure of non-cash financing activities:  
Offering costs included in accrued expenses, formation and offering costs 30,061
Advisory fee 10,764,000
Deferred underwriting compensation 10,764,000
Offering costs charged to additional paid in capital 1,028,484
Initial classification of warrant liability - public $ 4,305,600